New Advances in Prostate Cancer Diagnosis: Outcomes from the 2022 Panjiayuan Consensus Conference
The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant...
24-Oct-2024 9:55 AM EDT
Add to Favorites